• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines.

Stephanie Nolen
Author: Stephanie Nolen

Written by

Stephanie Nolen

in

Brazil, China, Colombia, Developing Countries, Drugs (Pharmaceuticals), Epidemics, Generic Brands and Products, Gilead Sciences Inc, Intellectual Property, Inventions and Patents, lenacapavir, Medicine and Health, Prices (Fares, Fees and Rates)
←A GOP Congressman Tweeted A JD Vance Image That Must Be Seen To Be Believed
JD Vance Defends His Alarming Debate Answer About The 2020 Election Results→

More posts

  • Salesforce reportedly planning $25 billion bond sale to help fund $50 billion buyback

  • Yann LeCun raises $1 billion for his Advanced Machine Intelligence Labs, breaking European records

  • Officer shot in ‘active shooter incident’ in Baltimore, suspect also shot: Police

  • Op-Ed: Rev. Jesse Jackson’s HBCU Roots Show How Student Leadership Shapes Black Political Power

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube